Dataset Information


Glycan masking of hemagglutinin for adenovirus vector and recombinant protein immunizations elicits broadly neutralizing antibodies against H5N1 avian influenza viruses.

ABSTRACT: The highly pathogenic avian influenza (HPAI) H5N1 virus, a known trigger of diseases in poultry and humans, is perceived as a serious threat to public health. There is a clear need for a broadly protective H5N1 vaccine or vaccines for inducing neutralizing antibodies against multiple clades/subclades. We constructed single, double, and triple mutants of glycan-masked hemagglutiinin (HA) antigens at residues 83, 127 and 138 (i.e., g83, g127, g138, g83+g127, g127+g138, g83+g138 and g83+g127+g138), and then obtained their corresponding HA-expressing adenovirus vectors and recombinant HA proteins using a prime-boost immunization strategy. Our results indicate that the glycan-masked g127+g138 double mutant induced more potent HA-inhibition, virus neutralization antibodies, cross-clade protection against heterologous H5N1 clades, correlated with the enhanced bindings to the receptor binding sites and the highly conserved stem region of HA. The immune refocusing stem-specific antibodies elicited by the glycan-masked H5HA g127+g138 and g83+g127+g138 mutants overlapped with broadly neutralizing epitopes of the CR6261 monoclonal antibody that neutralizes most group 1 subtypes. These findings may provide useful information in the development of a broadly protective H5N1 influenza vaccine.


PROVIDER: S-EPMC3966833 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5021406 | BioStudies
2009-01-01 | S-EPMC2695938 | BioStudies
2009-01-01 | S-EPMC2758658 | BioStudies
2008-01-01 | S-EPMC2596486 | BioStudies
2013-01-01 | S-EPMC4222342 | BioStudies
1000-01-01 | S-EPMC5607339 | BioStudies
2012-01-01 | S-EPMC3486276 | BioStudies
2006-01-01 | S-EPMC2762105 | BioStudies
2012-01-01 | S-EPMC7095019 | BioStudies
2014-01-01 | S-EPMC3962274 | BioStudies